Fortress Biotech
FBIO
#9836
Rank
A$0.12 B
Marketcap
A$3.87
Share price
-1.07%
Change (1 day)
8.01%
Change (1 year)

Earnings for Fortress Biotech (FBIO)

Earnings in 2026 (TTM): A$0.19 Billion

According to Fortress Biotech 's latest financial reports the company's current earnings are A$66.16 Million. In 2025 the company made an earning of -A$47.08 Million, an increase over its 2024 earnings that were of -A$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Fortress Biotech from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.19 B-507.85%
2025 -A$47.08 Million-72.02%
2024 -A$0.17 Billion-21.6%
2023 -A$0.22 Billion-28.03%
2022 -A$0.3 Billion29.88%
2021 -A$0.23 Billion59.8%
2020 -A$0.15 Billion1.17%
2019 -A$0.15 Billion-19.84%
2018 -A$0.18 Billion28.99%
2017 -A$0.14 Billion37.92%
2016 -A$99.58 Million32.31%
2015 -A$75.27 Million164.31%
2014 -A$28.48 Million-45.14%
2013 -A$51.91 Million37.55%
2012 -A$37.74 Million-22.91%
2011 -A$48.95 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Veracyte
VCYT
A$0.12 B-31.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-A$0.17 Billion-188.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
-A$47.53 Million-125.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Dynavax Technologies
DVAX
-A$47.34 Million-125.43%๐Ÿ‡บ๐Ÿ‡ธ USA